anchor instance (Q86484)

From ScienceSource
Jump to: navigation, search
No description defined
edit
Language Label Description Also known as
English
anchor instance
No description defined

    Statements

    pemafibrate were considered clinically negligible or not associated with treatment, even in patients with
    0 references
    at baseline. A small increase in serum homocysteine levels (by 2.4 μmol/L) was noted at a dose of
    0 references
    428
    0 references
    7
    0 references
    32,275
    0 references
    16 April 2019
    0 references
    0 references
    Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia. (5628452)
    0 references
     
    edit
      edit
        edit
          edit
            edit
              edit